Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia
Titel:
Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia
Auteur:
Tsimberidou, Apostolia Cortes, Jorge Thomas, Deborah Garcia-Manero, Guillermo Verstovsek, Srdan Faderl, Stephan Albitar, Maher Kantarjian, Hagop Estey, Elihu Giles, Francis J.